Literature DB >> 15249530

The clinical and economic burden of fibromyalgia compared with diabetes mellitus and hypertension among Bedouin women in the Negev.

Yariv Doron1, Roni Peleg, Aya Peleg, Lily Neumann, Dan Buskila.   

Abstract

BACKGROUND: Fibromyalgia (FM) is a common idiopathic chronic, widespread pain syndrome with tenderness in anatomically defined tender points.
OBJECTIVES: The purpose of the present study was to describe and characterize the economic and daily work burden of FM compared with diabetes mellitus and hypertension.
METHODS: A retrospective study was conducted in 2001 in a primary care clinic, the Kuseife clinic of the Clalit Health Services. Data for the three study groups were obtained from the computerized database of the Kuseife clinic and the Negev District, Israel. The study group included 102 FM patients. The control groups included 102 diabetes patients and 103 patients with hypertension.
RESULTS: Hospitalization and hospital day care services were the main expenses incurred by patients in this study. There were no differences among the study groups in any cost parameter examined except for the cost of diagnostic tests (P < 0.01), which was less for FM patients. FM patients were referred to specialists and diagnostic procedures more frequently than the control groups. No statistical difference was found in the total number of clinic visits, but FM patients visited physicians more frequently and visited nurses less frequently than patients in the other two groups (P < 0.05).
CONCLUSIONS: FM patients consume health care resources to a similar extent to patients with other chronic diseases such as diabetes mellitus and hypertension, but the latter usually receive much more attention from the health care system. Greater awareness of this disorder can improve management and facilitate planning of health care resources, thus improving quality of care.

Entities:  

Mesh:

Year:  2004        PMID: 15249530     DOI: 10.1093/fampra/cmh411

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  10 in total

1.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 2.  Health and morbidity among Bedouin women in southern Israel: a descriptive literature review of the past two decades.

Authors:  Yulia Treister-Goltzman; Roni Peleg
Journal:  J Community Health       Date:  2014-08

Review 3.  The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Alireza Amir Maafi; Babak Ghalebaghi
Journal:  Korean J Pain       Date:  2015-07-01

4.  Fibromyalgia-related costs and loss of productivity: a substantial societal burden.

Authors:  Anaïs Lacasse; Patricia Bourgault; Manon Choinière
Journal:  BMC Musculoskelet Disord       Date:  2016-04-16       Impact factor: 2.362

5.  Severe forms of fibromyalgia with acute exacerbation of pain: costs, comorbidities, and length of stay in inpatient care.

Authors:  Tobias Romeyke; Elisabeth Noehammer; Hans Christoph Scheuer; Harald Stummer
Journal:  Clinicoecon Outcomes Res       Date:  2017-06-01

6.  Cost-utility of an 8-month aquatic training for women with fibromyalgia: a randomized controlled trial.

Authors:  Narcís Gusi; Pablo Tomas-Carus
Journal:  Arthritis Res Ther       Date:  2008-02-22       Impact factor: 5.156

Review 7.  Exploring Genetic Susceptibility to Fibromyalgia.

Authors:  Dong-Jin Park; Ji-Hyoun Kang; Yi-Rang Yim; Ji-Eun Kim; Jeong-Won Lee; Kyung-Eun Lee; Lihui Wen; Tae-Jong Kim; Yong-Wook Park; Shin-Seok Lee
Journal:  Chonnam Med J       Date:  2015-08-17

8.  Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.

Authors:  X Peng; P Sun; D Novick; J Andrews; S Sun
Journal:  J Pain Res       Date:  2014-01-09       Impact factor: 3.133

9.  A pilot study of complementary and alternative medicine use in patients with fibromyalgia syndrome.

Authors:  Geoffrey C Wall; Linda L Krypel; Michael J Miller; Derek M Rees
Journal:  Pharm Pract (Granada)       Date:  2007-10

Review 10.  New insights into the genetics of fibromyalgia.

Authors:  Dong-Jin Park; Shin-Seok Lee
Journal:  Korean J Intern Med       Date:  2017-10-23       Impact factor: 2.884

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.